Introduction: Traumatic brain injury (TBI) is a major worldwide neurological disorder of
epidemic proportions. To date, there are still no FDA-approved therapies to treat any forms …

Postmortem investigations have implicated astrocytes in many neurological and psychiatric
conditions. Multiple brain regions from individuals with major depressive disorder (MDD) …

With the contribution from more than one hundred CNS neurotrauma experts, this book
provides a comprehensive and up-to-date account on the latest developments in the area of …

Traumatic brain injury (TBI) is a major global health issue, with outcomes spanning from
intracranial bleeding, debilitating sequelae, and invalidity with consequences for individuals …

Objectives: Both delirium duration and delirium severity are associated with adverse patient
outcomes. Serum biomarkers associated with delirium duration and delirium severity in ICU …

Objectives S100B has been proposed as a putative biochemical marker in determining the
extent of brain injury and corresponding prognosis in neurotrauma. The aim of this study …

Traumatic brain injury (TBI) is exceptionally prevalent in society and often imposes a
massive burden on patients' families and poor prognosis. The evidence reviewed here …

Objective: To determine temporal profile and prognostic ability of S100B protein and neuron-
specific enolase (NSE) for prediction of short/long-term mortality in patients suffering from …

The Australian Traumatic Brain Injury Initiative (AUS-TBI) aims to co-design a data resource
to predict outcomes for people with moderate-severe traumatic brain injury (TBI) across …

S100 calcium binding protein B (S100B), a well-studied marker for neurologic injury, has
been suggested as a candidate for predicting outcome after subarachnoid hemorrhage. We …